Category: Finance
-
European Venture Volume Up, Science Company Investments Drop
Venture capital (VC) investment volume rose in the second quarter of 2012 compared to the second quarter of 2011, but the number of VC deals dropped sharply. The number and volume of investments in European science-based companies, says financial industry research service Dow Jones VentureSource, declined by double-digit percentages in the second quarter of 2012…
-
Company, University Share Stem Cell Research Funds
Researchers at StemCells Inc. in Newark, California and University of California in Irvine will share a $20 million award from the California Institute for Regenerative Medicine (CIRM) to conduct research on stem cells leading to clinical trials to treat cervical spinal cord injury. The grant was one of several awards announced last week by CIRM,…
-
University, Company to Develop Advanced Infrared Detectors
Rochester Institute of Technology in New York received a National Science Foundation grant for research on infrared detectors grown on silicon wafers, with potential applications in astronomy, remote sensing, and medical imaging. The $1.2 million award will fund RIT’s development, fabrication, and testing of a new type of detectors grown on silicon wafer substrates by…
-
Space Institute Funds Medical Product Commercialization
National Space Biomedical Research Institute in Houston will support the commercialization of two health care products made by small U.S. companies. The awards of $100,000 each were made by the institute’s Space Medicine and Related Technologies Commercialization Assistance Program (SMARTCAP) to ACell Inc., of Columbia, Maryland and Enterade USA of Newberry, Florida. SMARTCAP provides seed…
-
Award Funds Malaria Drug Anti-Counterfeiting Technology
The organization Saving Lives at Birth has awarded a Boston University engineering professor a grant to complete development of technology that can determine the potency of drugs like those to treat malaria. The two-year $250,000 grant will fund Muhammad Zaman’s (pictured left) work on PharmaCheck, a handheld microfluidic — lab-on-a-chip — device. PharmaCheck scans pills…
-
Small Business Grant Awarded for Artificial Pancreas Insulin
Biodel Inc., a biopharmaceutical company in Danbury, Connecticut, has received a Small Business Innovation Research (SBIR) grant to develop concentrated faster-acting insulin formulations for use in an artificial pancreas. The two-year grant totaling $582,473 was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases of National Institutes of Health (NIH). Biodel notes…
-
$2.6B Venture Fund Aims for Health Care, Energy Companies
New Enterprise Associates Inc., a venture capital company in Chevy Chase, Maryland, says it has closed its 14th fund with $2.6 billion in capital. New Enterprise says the new fund is its third consecutive property exceeding $2.5 billion, and brings the company’s total committed capital to more than $13 billion across all of its funds.…
-
Purdue Awards $200K for Research Commercialization
The Trask Innovation Fund at Purdue University in Indiana has awarded some $200,000 to help Purdue researchers take their discoveries to market. The awards cover research on alternative fuels, pharmaceutical drug dosage forms, assisted reproductive technology, and a mobile app for note-taking. The Trask Innovation Fund is a program of the Purdue Research Foundation to…
-
NIH to Fund Development of Organ-On-Chip Devices
National Institutes of Health will support 17 research initiatives leading to development of microfluidic chips that simulate the structure and function of human organs. NIH’s National Center for Advancing Translational Sciences is funding the projects for five years at a total cost of $70 million. The project involves collaboration with the Defense Advanced Research Projects…
-
Biopharma Secures $38.5 Million in Series D Funds
Chiasma Inc., a biopharmaceutical company in Jerusalem, Israel, has closed its $38.5 million series D funding round, the fourth cycle of financing after initial start-up. The round was led by by new investor Abingworth and current investor MPM Capital, with participation from current share holders 7 Med Health Ventures, ARCH Venture Partners, F3 Ventures, and…